ESR1 and triple-negative breast carcinoma: A study of the relationship of MCTS1 and IL-6 with the clinical path of thedisease revealed a positive correlation between the proteins levels in allpatients with triple-negative breast cancer with a deficient expression of theepidermal growth factor receptor (HER2), estrogen receptor (ER), andprogesterone receptor (PR).